XML 130 R112.htm IDEA: XBRL DOCUMENT v3.19.2
Segment and Geographic Information , Reconciliation of Income Before Provision for Income Taxes from Segments to Consolidated (Details) - USD ($)
12 Months Ended
Apr. 26, 2019
Apr. 27, 2018
Apr. 28, 2017
Segment Reporting Information [Line Items]      
Amortization of intangible assets $ (1,764,000,000) $ (1,823,000,000) $ (1,980,000,000)
Certain litigation charges (166,000,000) (61,000,000) (300,000,000)
Divestiture-related items     0
Gain on sale of businesses 0 697,000,000 0
Income (loss) before income taxes 5,197,000,000 5,675,000,000 4,602,000,000
Reportable segments      
Segment Reporting Information [Line Items]      
Segment EBITA 11,869,000,000 11,498,000,000 11,126,000,000
Interest income 283,000,000 397,000,000 366,000,000
Reportable segments | Cardiac and Vascular Group      
Segment Reporting Information [Line Items]      
Segment EBITA 4,541,000,000 4,460,000,000 4,134,000,000
Reportable segments | Minimally Invasive Therapies Group      
Segment Reporting Information [Line Items]      
Segment EBITA 3,266,000,000 3,346,000,000 3,434,000,000
Reportable segments | Restorative Therapies Group      
Segment Reporting Information [Line Items]      
Segment EBITA 3,323,000,000 3,058,000,000 2,868,000,000
Reportable segments | Diabetes Group      
Segment Reporting Information [Line Items]      
Segment EBITA 739,000,000 634,000,000 690,000,000
Segment reconciling items      
Segment Reporting Information [Line Items]      
Interest expense (1,444,000,000) (1,146,000,000) (1,094,000,000)
Amortization of intangible assets (1,764,000,000) (1,823,000,000) (1,980,000,000)
Corporate (1,253,000,000) (1,437,000,000) (1,232,000,000)
Centralized distribution costs (1,688,000,000) (1,936,000,000) (1,543,000,000)
Restructuring and associated costs (407,000,000) (107,000,000) (373,000,000)
Acquisition-related items (88,000,000) (132,000,000) (230,000,000)
Certain litigation charges (166,000,000) (61,000,000) (300,000,000)
Gain/(loss) on minority investments 62,000,000 0 0
IPR&D charges (58,000,000) (46,000,000) 0
Exit of businesses (149,000,000) 0 0
Divestiture-related items 0 (115,000,000) 0
Gain on sale of businesses 0 697,000,000 0
Contribution to Medtronic Foundation 0 (80,000,000) (100,000,000)
Hurricane Maria 0 (34,000,000) 0
Impact of inventory step-up $ 0 $ 0 $ (38,000,000)